{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:35:35Z","timestamp":1794922535936,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yanhui Gao","award":["202206010009"],"award-info":[{"award-number":["202206010009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-24055-7","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T05:59:33Z","timestamp":1755323973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CD4\/CD8 ratio trajectories and their impact on prognosis: a 15-year retrospective longitudinal cohort study of people living with HIV"],"prefix":"10.1186","volume":"25","author":[{"given":"Lihui","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"issue":"12","key":"24055_CR1","doi-asserted-by":"publisher","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","volume":"8","author":"H Samji","year":"2013","unstructured":"Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8(12):e81355.","journal-title":"PLoS One"},{"issue":"2","key":"24055_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/infdis\/jit147","volume":"208","author":"KM Erlandson","year":"2013","unstructured":"Erlandson KM, Allshouse AA, Jankowski CM, Lee EJ, Rufner KM, Palmer BE, Wilson CC, MaWhinney S, Kohrt WM, Campbell TB. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis. 2013;208(2):249\u201359.","journal-title":"J Infect Dis"},{"issue":"5","key":"24055_CR3","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.4049\/jimmunol.1302596","volume":"192","author":"M Buggert","year":"2014","unstructured":"Buggert M, Frederiksen J, Noyan K, Svard J, Barqasho B, Sonnerborg A, Lund O, Nowak P, Karlsson AC. Multiparametric bioinformatics distinguish the CD4\/CD8 ratio as a suitable laboratory predictor of combined T cell pathogenesis in HIV infection. J Immunol. 2014;192(5):2099\u2013108.","journal-title":"J Immunol"},{"issue":"6","key":"24055_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1097\/QAD.0000000000001005","volume":"30","author":"JL Castilho","year":"2016","unstructured":"Castilho JL, Shepherd BE, Koethe J, Turner M, Bebawy S, Logan J, Rogers WB, Raffanti S, Sterling TR. CD4+\/CD8\u2009+\u2009ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy. AIDS. 2016;30(6):899\u2013908.","journal-title":"AIDS"},{"issue":"5","key":"24055_CR5","doi-asserted-by":"publisher","first-page":"e1004078","DOI":"10.1371\/journal.ppat.1004078","volume":"10","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, et al. HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8\u2009+\u2009T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014;10(5):e1004078.","journal-title":"PLoS Pathog"},{"issue":"6","key":"24055_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/jnci\/djac053","volume":"114","author":"JL Castilho","year":"2022","unstructured":"Castilho JL, Bian A, Jenkins CA, Shepherd BE, Sigel K, Gill MJ, Kitahata MM, Silverberg MJ, Mayor AM, Coburn SB, et al. CD4\/CD8 ratio and cancer risk among adults with HIV. J Natl Cancer Inst. 2022;114(6):854\u201362.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"24055_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jinf.2012.09.013","volume":"66","author":"S Serrano-Villar","year":"2013","unstructured":"Serrano-Villar S, Guti\u00e9rrez C, Vallejo A, Hernandez-Novoa B, Diaz L, Abad FM, Madrid N, Dronda F, Zamora J, Munoz-Fernandez MA, et al. The CD4\/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect. 2013;66(1):57\u201366.","journal-title":"J Infect"},{"key":"24055_CR8","unstructured":"Li T. Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2021 Edition)."},{"issue":"2","key":"24055_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/10705511.2014.882690","volume":"21","author":"SY Kim","year":"2014","unstructured":"Kim SY. Determining the number of latent classes in Single- and Multi-Phase growth mixture models. Struct Equ Model. 2014;21(2):263\u201379.","journal-title":"Struct Equ Model"},{"issue":"2","key":"24055_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jpepsy\/jst085","volume":"39","author":"KS Berlin","year":"2014","unstructured":"Berlin KS, Parra GR, Williams NA. An introduction to latent variable mixture modeling (part 2): longitudinal latent class growth analysis and growth mixture models. J Pediatr Psychol. 2014;39(2):188\u2013203.","journal-title":"J Pediatr Psychol"},{"issue":"6","key":"24055_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/00273171.2010.531230","volume":"45","author":"KJ Grimm","year":"2010","unstructured":"Grimm KJ, Ram N, Estabrook R. Nonlinear structured growth mixture models in Mplus and OpenMx. Multivar Behav Res. 2010;45(6):887\u2013909.","journal-title":"Multivar Behav Res"},{"key":"24055_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jad.2022.05.117","volume":"311","author":"M Gil","year":"2022","unstructured":"Gil M, Kim SS. Developmental trajectories of self-esteem, the related predictors, and depression: a growth mixture modeling approach. J Affect Disord. 2022;311:622\u201330.","journal-title":"J Affect Disord"},{"issue":"7","key":"24055_CR13","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1111\/ajt.13717","volume":"16","author":"R Sapir-Pichhadze","year":"2016","unstructured":"Sapir-Pichhadze R, Pintilie M, Tinckam KJ, Laupacis A, Logan AG, Beyene J, Kim SJ. Survival analysis in the presence of competing risks: the example of waitlisted kidney transplant candidates. Am J Transpl. 2016;16(7):1958\u201366.","journal-title":"Am J Transpl"},{"issue":"6","key":"24055_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601\u20139.","journal-title":"Circulation"},{"issue":"9","key":"24055_CR15","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/QAD.0b013e32835faa72","volume":"27","author":"T Sainz","year":"2013","unstructured":"Sainz T, Serrano-Villar S, Diaz L, Gonzalez TM, Gurbindo MD, de Jose MI, Mellado MJ, Ramos JT, Zamora J, Moreno S, et al. The CD4\/CD8 ratio as a marker T-cell activation, senescence and activation\/exhaustion in treated HIV-Infected children and young Adults[J]. AIDS. 2013;27(9):1513\u20136.","journal-title":"AIDS"},{"issue":"9","key":"24055_CR16","doi-asserted-by":"publisher","first-page":"e016886","DOI":"10.1136\/bmjopen-2017-016886","volume":"7","author":"SS Lee","year":"2017","unstructured":"Lee SS, Wong NS, Wong B, Wong KH, Chan K. Combining CD4 recovery and CD4: CD8 ratio restoration as an indicator for evaluating the outcome of continued antiretroviral therapy: an observational cohort study. BMJ Open. 2017;7(9):e016886.","journal-title":"BMJ Open"},{"issue":"10","key":"24055_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077665","volume":"8","author":"V Leung","year":"2013","unstructured":"Leung V, Gillis J, Raboud J, Cooper C, Hogg RS, Loutfy MR, Machouf N, Montaner JS, Rourke SB, Tsoukas C, et al. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy. PLoS One. 2013;8(10): e77665.","journal-title":"PLoS One"},{"key":"24055_CR18","doi-asserted-by":"publisher","first-page":"827689","DOI":"10.3389\/fmicb.2022.827689","volume":"13","author":"F Qin","year":"2022","unstructured":"Qin F, Lv Q, Hong W, Wei D, Huang K, Lan K, Chen R, Liu J, Liang B, Liang H, et al. Association between CD4\/CD8 ratio recovery and chronic kidney disease among human immunodeficiency virus-infected patients receiving antiretroviral therapy: a 17-year observational cohort study. Front Microbiol. 2022;13:827689.","journal-title":"Front Microbiol"},{"issue":"3","key":"24055_CR19","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/S2352-3018(15)00006-5","volume":"2","author":"C Mussini","year":"2015","unstructured":"Mussini C, Lorenzini P, Cozzi-Lepri A, Lapadula G, Marchetti G, Nicastri E, Cingolani A, Lichtner M, Antinori A, Gori A, et al. CD4\/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. Lancet HIV. 2015;2(3):e98\u2013106.","journal-title":"Lancet HIV"},{"key":"24055_CR20","doi-asserted-by":"publisher","first-page":"104072","DOI":"10.1016\/j.ebiom.2022.104072","volume":"80","author":"S Serrano-Villar","year":"2022","unstructured":"Serrano-Villar S, Wu K, Hunt PW, Lok JJ, Ron R, Sainz T, Moreno S, Deeks SG, Bosch RJ. Predictive value of CD8\u2009+\u2009T cell and CD4\/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events. EBioMedicine. 2022;80:104072.","journal-title":"EBioMedicine"},{"issue":"1","key":"24055_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/cid\/ciaa1137","volume":"73","author":"F Caby","year":"2021","unstructured":"Caby F, Guiguet M, Weiss L, Winston A, Miro JM, Konopnicki D, Le Moing V, Bonnet F, Reiss P, Mussini C, et al. CD4\/CD8 ratio and the risk of Kaposi sarcoma or Non-Hodgkin lymphoma in the context of efficiently treated human immunodeficiency virus (HIV) infection: a collaborative analysis of 20 European cohort studies. Clin Infect Dis. 2021;73(1):50\u20139.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"24055_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/cid\/cix466","volume":"65","author":"A Trickey","year":"2017","unstructured":"Trickey A, May MT, Schommers P, Tate J, Ingle SM, Guest JL, Gill MJ, Zangerle R, Saag M, Reiss P, et al. CD4:CD8 ratio and CD8 count as prognostic markers for mortality in human immunodeficiency virus-infected patients on antiretroviral therapy: the antiretroviral therapy cohort collaboration (ART-CC). Clin Infect Dis. 2017;65(6):959\u201366.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24055-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24055-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24055-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T14:49:42Z","timestamp":1757429382000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24055-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24055"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24055-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"5 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee at the Clinic of Guangzhou Eighth People\u2019s Hospital Guangzhou Medical University (study approval number: 202309246). All PLHIV were adults and provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2794"}}